Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
VCD Regimen (APL) VCD Regimen (APL)
VCD Regimen (APL) and Graspa, Daunorubicin + Cytarabine...
Upcoming
AVD Regimen (APL) AVD Regimen (APL)
AVD Regimen (APL) and Graspa, Daunorubicin + Cytarabine...
Upcoming
Campath/MabCampath Campath/MabCampath
Campath/MabCampath and Treanda, Arzerra,
Upcoming
Treanda Treanda
Treanda and Campath/MabCampath, Arzerra,
Upcoming
Fludara Fludara
Fludara and Campath/MabCampath, Treanda,
Upcoming
FCR Regimen FCR Regimen
FCR Regimen and Campath/MabCampath, Treanda,
Upcoming
FC Regimen FC Regimen
FC Regimen and Campath/MabCampath, Treanda,
Upcoming
Bosutinib Bosutinib
Bosutinib and Lab-on-chips (Microfluidics),
Upcoming
Gleevec Gleevec
Gleevec and Lab-on-chips (Microfluidics), Microreactors,...
Upcoming
Sprycel Sprycel
Sprycel and Lab-on-chips (Microfluidics), Microreactors,...
Upcoming
Phase II Phase II
Phase II and Phase I and Phase III adds up to total Pipeline Drugs market. ...
Upcoming
Phase III Phase III
Phase III and Phase I and Phase II adds up to total Pipeline Drugs market. ...
Upcoming
Phase I (NHL) Phase I (NHL)
Phase I (NHL) and Phase II (NHL) and Phase III (NHL) adds up to total...
Upcoming
Phase II (NHL) Phase II (NHL)
Phase II (NHL) and Phase I (NHL) and Phase III (NHL) adds up to total...
Upcoming
Phase III (NHL) Phase III (NHL)
Phase III (NHL) and Phase I (NHL) and Phase II (NHL) adds up to total...
Upcoming
Phase I (AML) Phase I (AML)
Phase I (AML) and Phase II (AML) and Phase III (AML) adds up to total...
Upcoming
Phase II (AML) Phase II (AML)
Phase II (AML) and Phase I (AML) and Phase III (AML) adds up to total...
Upcoming
Phase III (AML) Phase III (AML)
Phase III (AML) and Phase I (AML) and Phase II (AML) adds up to total...
Upcoming
Phase I (B-cell Lymphoma) Phase I (B-cell Lymphoma)
Phase I (B-cell Lymphoma) and Phase II (B-cell Lymphoma) and
Upcoming
Phase II (B-cell Lymphoma) Phase II (B-cell Lymphoma)
Phase II (B-cell Lymphoma) and Phase I (B-cell Lymphoma) and
Upcoming
2987 reports | Show
Connect With Us
US/CAN : +1-888-502-0539